Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized open-label crossover self-controlled multicenter study of a [13C]-urea breath test kit for diagnosis of Helicobacter pylori infection
CTR20261797Phase 3Active
- Sponsor
- Hunan Huana Pharmaceuticals
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of urea in Helicobacter pylori infection (2 arms), sponsored by Hunan Huana Pharmaceuticals. Primary endpoints: Sensitivity and Specificity. Started Jul 2026; status: active.
02
Drugs
urea
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on CTR20261797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261797.